Trastuzumab Emtansine (T-DM1)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Trastuzumab Emtansine (T-DM1), covering 2013-07-18 to 2013-07-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1, T-DM1) in Combination With Pertuzumab Administered to Patients With Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer Who Have Previously Received Trastuzumab [Phase 1, Phase 2]